iSpecimen Inc.
ISPC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9 | $10 | $10 | $11 |
| % Growth | -6.4% | -4.6% | -6.6% | – |
| Cost of Goods Sold | $5 | $5 | $5 | $5 |
| Gross Profit | $4 | $5 | $6 | $6 |
| % Margin | 42.9% | 51.4% | 54.3% | 52.9% |
| R&D Expenses | $4 | $4 | $3 | $2 |
| G&A Expenses | $8 | $8 | $9 | $7 |
| SG&A Expenses | $13 | $12 | $12 | $9 |
| Sales & Mktg Exp. | $5 | $4 | $3 | $2 |
| Other Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Expenses | $17 | $16 | $16 | $12 |
| Operating Income | -$13 | -$11 | -$10 | -$6 |
| % Margin | -137% | -112.5% | -97.9% | -53.2% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$3 |
| Pre-Tax Income | -$12 | -$11 | -$10 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$11 | -$10 | -$9 |
| % Margin | -134.5% | -111.8% | -98.5% | -80.5% |
| EPS | -17.58 | -1.23 | -20.47 | -24.51 |
| % Growth | -1,329.3% | 94% | 16.5% | – |
| EPS Diluted | -17.58 | -24.55 | -20.44 | -24.51 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $2 |
| Depreciation & Amortization | -$0 | $2 | $1 | $1 |
| EBITDA | -$13 | -$9 | -$9 | -$6 |
| % Margin | -137% | -88.7% | -84.6% | -52.6% |